A powerful consortium of research organizations in Europe speaks out against a recent ruling to ban patenting of research on human embryonic stem cells.
Advertisement
The Scientist
Most Recent
A traditional drug to treat insomnia shows surprising promise in awaking minimally conscious patients.
After 6 months in orbit, Caenorhabditis elegans return to Earth—alive and well.
Researchers find that newts are capable of regenerating body parts well into old age.
Full Professor and Senior Research Group Leader, German Center for Neurodegenerative Diseases. Age: 42
Cut off a newt’s tail or a leg, or remove a lens from its eye, and it grows back. However, whether newts can continue to do this throughout their lives, or lose the ability as they get older, has remained a mystery. Now, in an experiment spanning 16
Tagging antibodies with rare earth metals instead of fluorescent molecules turns a veteran technique into a high-throughput powerhouse.
The Human Society is still concerned that a US primate research center of illegally breeding federally-owned chimpanzees.
Following last week’s ruling by the European Court of Justice that research procedures involving human embryonic stem cells cannot be patented, European researchers, lawyers, and investors are striving to put a positive spin on the decision. "If anyt
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
